Valeant Pharmaceuticals is understood to be considering issuing new preferred equity to some of its biggest shareholders to finance a sweetened, all-cash bid for Salix Pharmaceuticals.
PressDigest
Valeant seeks help of top shareholders for sweetened Salix bid
Valeant Pharmaceuticals is understood to be considering issuing new preferred equity to some of its biggest shareholders to finance a sweetened, all-cash bid for Salix Pharmaceuticals.